stella
beta
A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients — Stella
Recruiting
Back to Intrahepatic Cholangiocarcinoma trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Shanghai Changzheng Hospital, Naval Medical University, Shanghai, Shanghai Municipality
View full record on ClinicalTrials.gov